Inventor · disambiguated record
David Sperandio
Also filed as: SPERANDIO DAVID
25 granted patents·25 pending applications·276 citations·filing 2001–2024
96Inventor score
Files withGILEAD SCIENCES INC23BIOMEA FUSION INC8AXYS PHARM INC4TENAYA THERAPEUTICS INC4EPIODYNE INC2
Top patents by PatentIndex Score
50 records- 0196US11179397B2Imidazopyrimidine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·23 cites·13 claims
- 0294US11926622B2Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2022·Granted Mar 12, 2024·3 cites·20 claims
- 0394US11578066B1Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2022·Granted Feb 14, 2023·3 cites·28 claims
- 0494US8809330B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Aug 19, 2014·18 cites·10 claims
- 0594US8486938B2Pyrazolo[1,5-a]pyrimidines for antiviral treatmentBABAOGLU KERIM·Filed 2011·Granted Jul 16, 2013·25 cites·3 claims
- 0694US8324179B2Nucleoside analogs for antiviral treatmentCHEN JAMES M·Filed 2008·Granted Dec 4, 2012·72 cites·22 claims
- 0793US8980878B2Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Mar 17, 2015·20 cites·31 claims
- 0892US9238039B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Jan 19, 2016·13 cites·38 claims
- 0992US8999969B2Anti-RSV compoundsMACKMAN RICHARD L·Filed 2010·Granted Apr 7, 2015·38 cites·24 claims
- 1091US8946238B2Pyrazolo[1,5-A]pyrimidines as antiviral agentsGILEAD SCIENCES INC·Filed 2012·Granted Feb 3, 2015·15 cites·30 claims
- 1190US12049439B2Sulfinylaminobenzamide and sulfonylaminobenzamide derivativesORSOBIO INC·Filed 2021·Granted Jul 30, 2024·2 cites·50 claims
- 1289US9458145B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Oct 4, 2016·12 cites·9 claims
- 1384US11136290B2Sulfinylaminobenzamide and sulfonylaminobenzamide derivativesTHE LIVER COMPANY INC·Filed 2019·Granted Oct 5, 2021·5 cites·43 claims
- 1483US9504689B2Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2015·Granted Nov 29, 2016·3 cites·20 claims
- 1583US9255089B2Benzimidazolone derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Feb 9, 2016·7 cites·19 claims
- 1682US11352316B2Opioid receptor modulators and products and methods related theretoEPIODYNE INC·Filed 2020·Granted Jun 7, 2022·1 cites·20 claims
- 1779US12312345B2Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2023·Granted May 27, 2025·0 cites·32 claims
- 1879US9951065B2Benzimidazole and imadazopyridine carboximidamide compoundsGILEAD SCIENCES INC·Filed 2016·Granted Apr 24, 2018·3 cites·23 claims
- 1979US6861419B2Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2001·Granted Mar 1, 2005·12 cites·40 claims
- 2074US2023295201A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2173US9108953B2Quinoline derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Aug 18, 2015·1 cites·18 claims
- 2273US2024262795A1Pyrazine compounds as inhibitors of flt3BIOMEA FUSION INC·Filed 2024·Application pending·0 cites
- 2371US11945785B2Pyrazine compounds as inhibitors of FLT3BIOMEA FUSION INC·Filed 2022·Granted Apr 2, 2024·0 cites·28 claims
- 2467US9957275B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2017·Granted May 1, 2018·0 cites·17 claims
- 2566US2018298011A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2665US2022241281A1Imidazopyrimidine DerivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2762US2025312335A1Flt combination therapy for cancer and compositions thereforBIOMEA FUSION INC·Filed 2023·Application pending·0 cites
- 2862US2025353854A1Fused pyrimidine compounds as inhibitors of meninBIOMEA FUSION INC·Filed 2023·Application pending·0 cites
- 2962US2017190708A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3061US2022356196A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 3160US2024409558A1Irreversible inhibitors of krasBIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 3259US2025066386A1Inhibitors of krasBIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 3359US2016130275A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3458US10174038B2Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2017·Granted Jan 8, 2019·0 cites·20 claims
- 3558US2025136558A1Pyrazine compounds as irreversible inhibitors of flt3BIOMEA FUSION INC·Filed 2022·Application pending·0 cites
- 3657US2024124467A1Fused pyrimidine compounds as inhibitors of menin-mll interactionBIOMEA FUSION INC·Filed 2021·Application pending·0 cites
- 3756US2023123856A15-fluoronicotinamide derivatives and uses thereofTENAYA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3855US12466849B2Anti-viral and anti-tumoral compoundsYEDA RES & DEV·Filed 2022·Granted Nov 11, 2025·0 cites·20 claims
- 3955US2018282316A1Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 4055US2017029427A1Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4155US2024228521A1Anti-viral and anti-tumoral compounds, and uses thereofYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 4254US2021147343A1Opioid receptor modulators and products and methods related theretoEPIODYNE INC·Filed 2019·Application pending·0 cites
- 4352US10017501B2Benzimidazole derivatives as bromodomain inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 4452US2024158384A1Cb2 receptor agonistsUNIV LELAND STANFORD JUNIOR·Filed 2021·Application pending·0 cites
- 4550US2016235748A1Pyrazolo[1,5-a]pyrimidines as antiviral agentsGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4648US2005176797A12-[5-(5-Carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-YL]-succinic acid derivatives as factor viia inhibitorsAXYS PHARM INC·Filed 2004·Application pending·0 cites
- 4745US2003114457A12- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitorsAXYS PHARM INC·Filed 2002·Application pending·0 cites
- 4842US2005124614A13,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosisAXYS PHARM INC·Filed 2003·Application pending·0 cites
- 4937US2005026929A1Novel phenyl derivatives as inducers of apoptosisAXYS PHARM INC·Filed 2003·Application pending·0 cites
- 5035US2018179191A1Synthesis of a compound that modulates the activity of bromodomain-containing proteinsGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Sperandio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →